SEARCH

SEARCH BY CITATION

References

  • 1
    Dutta A, Saha C, Johnson C, Chalasani N. Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide survey. HEPATOLOGY 2009; 50: 19571962.
  • 2
    Neuschwander-Tetri B, Unalp A, Creer M. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. Arch Intern Med 2008; 168: 663666.
  • 3
    Klee G, Killeen A. College of American Pathologists 2003 fresh frozen serum proficiency testing studies. Arch Pathol Lab Med 2005; 129: 292293.
  • 4
    Dufour D, Lott J, Nolte F, Gretch D, Koff R, Seeff L. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 2000; 46: 20272049.
  • 5
    Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 110.
  • 6
    Browning J, Szczepaniak L, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. HEPATOLOGY 2004; 40: 13871395.
  • 7
    Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 2007; 53: 686692.
  • 8
    Uto H, Stuver S, Hayashi K, Kumagai K, Sasaki F, Kanmura S, et al. Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. HEPATOLOGY 2009; 50: 393399.
  • 9
    Tai D, Lin S, Sheen I, Chu C, Lin D, Liaw Y. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. HEPATOLOGY 2009; 49: 18591867.
  • 10
    Kim H, Nam C, Jee S, Han K, Oh D, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983.
  • 11
    Kim W, Flamm S, Di Bisceglie A, Bodenheimer H. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. HEPATOLOGY 2008; 47: 13631370.
  • 12
    Lee T, Kim W, Benson J, Therneau T, Melton LJ 3rd. Serum aminotransferase activity and mortality risk in a United States community. HEPATOLOGY 2008; 47: 880887.
  • 13
    Goessling W, Massaro J, Vasan R, D'Agostino RS, Ellison R, Fox C. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008; 135: 19351944.
  • 14
    Ruhl C, Everhart J. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009; 136: 477485.
  • 15
    Lok A, McMahon B. Chronic hepatitis B. HEPATOLOGY 2007; 45: 507539.